Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum

Keri A. Kles, Stephan R. Vavricka, Jerrold R. Turner, Mark W. Musch, Stephen B. Hanauer, Eugene B. Chang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Background: The aminosalicylates remain foundation therapy for mild-to-moderate ulcerative colitis. Pro-drug 5-aminosalicylic acid (5-ASA; mesalamine) formulations have been developed to prevent 5-ASA from the proximal absorption and release of mesalamine, to decrease inflammation, and to improve colonic absorption. Clinically, pro-drugs such as olsalazine have been associated with dose-dependent diarrhea, which was likely secondary to ileal secretion induced by the azo linkages, in 17% of patients. The present study tested the hypothesis that the use of all compounds with azo linkages leads to increased secretion. Methods: Intestinal tissue was randomly assigned to serve as controls or to receive brush border addition of equimolar concentrations of the compounds, and the change in short-circuit current was measured. Results: Mesalamine did not induce secretion at any dose. Mean equivalent doses (0. 1 to 10 mM) of balsalazide (range, 6.3 ± 1.5 to 16.7 ± 1.3 μA/cm2), olsalazine (range, 2.0 ± 1.0 to 7.0 ± 2.1 μA/cm2), and sulfasalazine (3.2 ± 1.1 to 6.2 ± 1.5 μA/cm2) significantly stimulated (P<0.001) secretion. The values for the effective dose that is half the maximal dose for secretion induced by sulfasalazine, olsalazine, and balsalazide were 0.4, 0.7, and 0.9 mM, respectively. Conclusions: This study is the first to demonstrate that the use of pro-drugs with azo bonds leads to increased ileal secretion at equimolar concentrations of 5-ASA. Physicians should use caution when providing higher doses of the pro-drug forms of 5-ASA to their patients, as this could lead to increased diarrhea.

Original languageEnglish (US)
Pages (from-to)253-257
Number of pages5
JournalInflammatory bowel diseases
Volume11
Issue number3
DOIs
StatePublished - Mar 2005

Keywords

  • Balsalazide
  • Mesalamine
  • Olsalazine
  • Sulfasalazine
  • Ulcerative colitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology

Fingerprint Dive into the research topics of 'Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum'. Together they form a unique fingerprint.

Cite this